Angiogenesis:A Promising Strategy for Tumor Therapy

Inhibiting angiogenesis is a promising strategy for treatment of cancer,whoes aim is to block tumor blood vessels and allow tumor die from starvation. In 1971 Folkman hypothesed that tumor growth is angiogenesis-dependent. In 2004 the first antiangiogenesis drug received approval from the US FDA for cancer treatment. Angiogenesis is now a hot area of tumor biology. Various novel targets,mechanism and inhibitors have been found. This review will focus on recent progress of these projects providing insight into angiogenesis research.